Market Overview
The India ophthalmology devices market is a segment of the broader Asia Pacific healthcare sector, covering surgical instruments, diagnostic and monitoring equipment, vision correction devices, and intraocular lenses (IOLs). The market was valued at approximately $0.98 billion in 2025 and is forecast to grow at a CAGR of roughly 7.81%, with analysis extending through the early 2030s across multiple industry assessments. Growth is anchored by a high burden of eye disease, particularly cataracts, which affect a large proportion of India's aging population, alongside increasing access to surgical interventions and diagnostic screening.
- •The market covers surgical devices, diagnostic and monitoring devices, and vision correction technologies
- •Cataract surgery and IOL implantation represent the largest volume segment in India
- •Industry forecasts extend through 2031 to 2036, reflecting long-term market confidence
Growth Drivers
A growing elderly demographic, rising prevalence of chronic conditions such as diabetes, and increasing awareness of eye health are propelling demand for ophthalmology devices across the country. Expanding hospital infrastructure and government health schemes improving access to surgical eye care in Tier 2 and Tier 3 cities are significant catalysts for market expansion. Technological advancements in minimally invasive surgical techniques, premium IOLs, and digital diagnostics are also encouraging adoption among healthcare providers and patients.
- •Rising diabetic population increases demand for diabetic retinopathy screening and treatment
- •Government initiatives such as the National Programme for Control of Blindness support cataract surgery access
- •Growing number of ophthalmic clinics and specialty hospitals expands device adoption nationwide
Segmentation and Regional Analysis
The market is segmented by device type into surgical devices, diagnostic and monitoring devices, vision correction devices, and intraocular lenses, with surgical and IOL products commanding the largest share. Geographically, demand is concentrated in major metropolitan areas and Tier 1 cities, though Tier 2 and Tier 3 cities are seeing accelerating growth as healthcare infrastructure and insurance coverage improve. Among device categories, cataract-related products dominate, while diagnostic imaging equipment such as OCT scanners and fundus cameras is gaining share.
- •Surgical devices include cataract surgery tools, glaucoma devices, and corneal implants
- •Diagnostic and monitoring segment covers optical coherence tomography scanners, fundus cameras, and tonometers
- •Western and southern regions of India show higher per-capita adoption of advanced ophthalmic devices
Trends and Outlook
What are the recent trends and outlook?
The market is expected to sustain its growth trajectory through 2031 and beyond, supported by continued investments in eye care infrastructure, rising patient volumes, and increasing affordability of advanced treatments. Premium segment demand, including multifocal and toric IOLs, is growing as disposable incomes rise and patients seek improved visual outcomes beyond basic monofocal lenses. Digital health integration, tele-ophthalmology, and AI-assisted diagnostic tools are emerging trends that are likely to reshape service delivery and device utilization over the forecast horizon.
- •Premium IOLs and refractive surgery devices are gaining market share as patient preferences evolve
- •AI-powered diagnostic tools and telemedicine platforms are expanding access to remote eye care
- •Domestic manufacturing initiatives may reduce import dependency and lower device costs over time
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.